These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7790079)

  • 21. Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans.
    Kwon-Chung KJ; Wickes BL; Booth JL; Vishniac HS; Bennett JE
    Infect Immun; 1987 Aug; 55(8):1751-4. PubMed ID: 3112009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical comparison of the Cu,Zn superoxide dismutases of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii.
    Hamilton AJ; Holdom MD
    Infect Immun; 1997 Feb; 65(2):488-94. PubMed ID: 9009302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
    Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
    Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans.
    Cheng PY; Sham A; Kronstad JW
    Infect Immun; 2009 Oct; 77(10):4284-94. PubMed ID: 19635827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolites released by Cryptococcus neoformans var. neoformans and var. gattii differentially affect human neutrophil function.
    Wright L; Bubb W; Davidson J; Santangelo R; Krockenberger M; Himmelreich U; Sorrell T
    Microbes Infect; 2002 Nov; 4(14):1427-38. PubMed ID: 12475633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii.
    Kwon-Chung KJ; Wickes BL; Stockman L; Roberts GD; Ellis D; Howard DH
    Infect Immun; 1992 May; 60(5):1869-74. PubMed ID: 1563776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptococcus neoformans variety gattii.
    Sorrell TC
    Med Mycol; 2001 Apr; 39(2):155-68. PubMed ID: 11346263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiologic differences between the two varieties of Cryptococcus neoformans.
    Kwon-Chung KJ; Bennett JE
    Am J Epidemiol; 1984 Jul; 120(1):123-30. PubMed ID: 6377880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of first-order Cryptococcus-specific T-suppressor cells on induction of cells responsible for delayed-type hypersensitivity.
    Murphy JW
    Infect Immun; 1985 May; 48(2):439-45. PubMed ID: 3157646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomes, a potential immunoadjuvant and carrier for a cryptococcal vaccine.
    Lambros MP; Schafer F; Blackstock R; Murphy JW
    J Pharm Sci; 1998 Sep; 87(9):1144-8. PubMed ID: 9724568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).
    Kwon-Chung KJ; Polacheck I; Bennett JE
    J Clin Microbiol; 1982 Mar; 15(3):535-7. PubMed ID: 7042750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel therapeutic approach by culture filtrate of Cryptococcus neoformans var. gattii (CneF) in experimental immune complex glomerulonephritis.
    Mirshafiey A; Mehrabian F; Razavi A; Shidfar MR; Namaki S
    Gen Pharmacol; 2000 May; 34(5):311-9. PubMed ID: 11368886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil-mediated antifungal activity against highly virulent Cryptococcus gattii strain R265.
    Ueno K; Yanagihara N; Otani Y; Shimizu K; Kinjo Y; Miyazaki Y
    Med Mycol; 2019 Nov; 57(8):1046-1054. PubMed ID: 30668754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine monoclonal antibodies recognizing a non-capsular antigen that distinguishes between Cryptococcus neoformans var. neoformans and C. neoformans var. gattii.
    Hamilton AJ; Bartholomew MA; Figueroa J; Fenelon LE; Hay RJ
    Trans R Soc Trop Med Hyg; 1991; 85(1):123-7. PubMed ID: 2068741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.
    Monari C; Kozel TR; Bistoni F; Vecchiarelli A
    Infect Immun; 2002 Jul; 70(7):3363-70. PubMed ID: 12065474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the C-C chemokine, TCA3, in the protective anticryptococcal cell-mediated immune response.
    Doyle HA; Murphy JW
    J Immunol; 1999 Apr; 162(8):4824-33. PubMed ID: 10202026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taxonomic analysis of cryptococcus species complex strain S8012 revealed Cryptococcus gattii with high heterogeneity on the genetics.
    Chen M; Liao WQ; Wu SX; Yao ZR; Pan WH; Liao Y
    Chin Med J (Engl); 2011 Jul; 124(13):2051-6. PubMed ID: 22088469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.
    Dromer F; Gueho E; Ronin O; Dupont B
    J Clin Microbiol; 1993 Feb; 31(2):359-63. PubMed ID: 8432823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans.
    Murphy JW; Schafer F; Casadevall A; Adesina A
    Infect Immun; 1998 Jun; 66(6):2632-9. PubMed ID: 9596727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in Cryptococcus neoformans capsular polysaccharide structure influence assembly of alternative complement pathway C3 convertase on fungal surfaces.
    Washburn RG; Bryant-Varela BJ; Julian NC; Bennett JE
    Mol Immunol; 1991; 28(4-5):465-70. PubMed ID: 2062324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.